Table 1.
Tumor Type | Survival, % |
||
---|---|---|---|
Population-based9,12,20,32–42 | Present Study | ||
All ages | Low-grade glioma (WHO grades I/II) | 5y 91–95 | |
High-grade glioma (WHO grades III/IV) | 5y 21–28 | SEER 5y 26 | |
NRCT 5y 13 | |||
Ependymoma | 5y 52–83 | SEER 5y 73 | |
10y 55–60 | NRCT 5y 65 | ||
SEER 10y 70 | |||
NRCT 10y 57 | |||
Embryonal (medulloblastoma, sPNET) | 5y 46–70 | SEER 5y 67 | |
NRCT 5y 59 | |||
Medulloblastoma | 5y 56–87 | SEER 5y 71 | |
10y 52–55 | NRCT 5y 65 | ||
SEER 10y 69 | |||
NRCT 10y 59 | |||
sPNET | 5y 27 | SEER 5y 57 | |
10y 18–41 | NRCT 5y 33 | ||
SEER 10y 54 | |||
NRCT 10y 27 |
Abbreviation: WHO, World Health Organization.